TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Unimedic Pharma Holding AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 | 
| Turnover | 245 | 359 | 364 | 
| Financial expenses | 391 | 153 | 131 | 
| Earnings before taxes | -400 | -282 | -178 | 
| EBITDA | -49 | -140 | -51 | 
| Total assets | 7,334 | 7,301 | 7,449 | 
| Current assets | 31 | 281 | 114 | 
| Current liabilities | 545 | 682 | 1,219 | 
| Equity capital | 68 | 29 | 49 | 
| - share capital | 27   | 27 | 29 | 
| Employees (average) | 0   | 0   | 0 | 
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Solvency | 0.9% | 0.4% | 0.7% | 
| Turnover per employee | |||
| Profit as a percentage of turnover | -163.3% | -78.6% | -48.9% | 
| Return on assets (ROA) | -0.1% | -1.8% | -0.6% | 
| Current ratio | 5.7% | 41.2% | 9.4% | 
| Return on equity (ROE) | -588.2% | -972.4% | -363.3% | 
| Change turnover | -115 | 25 | 87 | 
| Change turnover % | -32% | 7% | 31% | 
| Chg. No. of employees | 0   | 0 | -3 | 
| Chg. No. of employees % | -100% | 
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    